Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Moleculin Biotech CS (MBRX)

1.09 -0.04 (-3.54%)

3/27/2017  4:00pm

Open:

1.10

Pre. Close:

1.13

High:

1.12

Low:

1.06

Volume:

761,160

Market Cap:

13.14M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.15 - 1.15

1.15 - 1.12

Low:

1.01 - 1.01

1.01 - 1.06

Close:

1.05 - 1.05

1.05 - 1.09

Technical analysis  (as of: 2017-03-27 4:36:19 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.51     One year: 1.76

Support:

Support1: 0.95    Support2: 0.79

Resistance:

Resistance1: 1.30    Resistance2: 1.51

Pivot:

1.13

Moving Averages:

MA(5): 1.15     MA(20): 1.13

MA(100): 1.97     MA(250):

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.11

%K %D:

%K(14,3): 18.37     %D(3): 28.81

RSI:

RSI(14): 44.16

52-Week:

High: 9.58  Low: 0.95  Change(%): -86.4

Average Vol(K):

3-Month: 854  10-Days 3383

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MBRX has closed above bottom band by 34.9%. Bollinger Bands are 71.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 27 Mar 2017 13:19:25 GMT
Moleculin Biotech, Inc. performed Very Well with a change of 1.8% in the Last ...

Wed, 22 Mar 2017 13:30:00 GMT
Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for Annamycin ...

Fri, 11 Feb 2011 11:27:25 GMT
Moleculin Biotech Inc. MBRX (US: Nasdaq)

Thu, 09 Feb 2017 16:05:21 GMT
Moleculin prices equity offering; shares down 20%

Mon, 27 Mar 2017 11:26:15 GMT
Sales Growth Analysis: Helix Energy Solutions Group, Inc. (HLX), Moleculin ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

15.76

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

248

Shares Short Prior Month (K)

346

Stock Financials

EPS

-0.320

EPS Est. Current Year

6.620

EPS Est. Next Year

7.190

EPS Est. Next Quarter

1.700

Forward EPS

Book Value (p.s.)

1.350

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-1.02

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-3.41

P/E Growth Ratio

-0.04

P/BV

0.81

P/S

P/CF

-16.84

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.